Gehlert DR - Search Results

1

Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.

Gehlert DR, Schober DA, Beavers L, Gadski R, Hoffman JA, Smiley DL, Chance RE, Lundell I, Larhammar D. Gehlert DR, et al. Mol Pharmacol. 1996 Jul;50(1):112-8. Mol Pharmacol. 1996. PMID: 8700103

2

The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction.

Berglund MM, Schober DA, Statnick MA, McDonald PH, Gehlert DR. Berglund MM, et al. Among authors: gehlert dr. J Pharmacol Exp Ther. 2003 Jul;306(1):147-56. doi: 10.1124/jpet.103.051227. Epub 2003 Mar 28. J Pharmacol Exp Ther. 2003. PMID: 12665544

3

[Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.

Gehlert DR, Gackenheimer SL, Schober DA. Gehlert DR, et al. Neurochem Int. 1992 Jul;21(1):45-67. doi: 10.1016/0197-0186(92)90067-2. Neurochem Int. 1992. PMID: 1303142

4

Expression cloning of a human brain neuropeptide Y Y2 receptor.

Gehlert DR, Beavers LS, Johnson D, Gackenheimer SL, Schober DA, Gadski RA. Gehlert DR, et al. Mol Pharmacol. 1996 Feb;49(2):224-8. Mol Pharmacol. 1996. PMID: 8632753

5

Pharmacological characterization of neuropeptide Y-(2-36) binding to neuropeptide Y Y1 and Y2 receptors.

Schober DA, Gackenheimer SL, Gehlert DR. Schober DA, et al. Among authors: gehlert dr. Eur J Pharmacol. 1996 Dec 30;318(2-3):307-13. doi: 10.1016/s0014-2999(96)00818-7. Eur J Pharmacol. 1996. PMID: 9016919

6

The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors.

Gehlert DR, Gackenheimer SL, Schober DA, Beavers L, Gadski R, Burnett JP, Mayne N, Lundell I, Larhammar D. Gehlert DR, et al. Eur J Pharmacol. 1996 Dec 30;318(2-3):485-90. doi: 10.1016/s0014-2999(96)00797-2. Eur J Pharmacol. 1996. PMID: 9016942

7

Analysis of NPY receptor subtypes in the human frontal cortex reveals abundant Y1 mRNA and binding sites.

Statnick MA, Schober DA, Mayne NG, Burnett JP, Gehlert DR. Statnick MA, et al. Among authors: gehlert dr. Peptides. 1997;18(1):137-43. doi: 10.1016/s0196-9781(96)00246-x. Peptides. 1997. PMID: 9114463

8

[125I]Leu31, Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors.

Gehlert DR, Schober DA, Gackenheimer SL, Beavers L, Gadski R, Lundell I, Larhammar D. Gehlert DR, et al. Peptides. 1997;18(3):397-401. doi: 10.1016/s0196-9781(96)00346-4. Peptides. 1997. PMID: 9145427

9

Identification of multiple neuropeptide Y receptor subtypes in the human frontal cortex.

Statnick MA, Schober DA, Gehlert DR. Statnick MA, et al. Among authors: gehlert dr. Eur J Pharmacol. 1997 Aug 13;332(3):299-305. doi: 10.1016/s0014-2999(97)01031-5. Eur J Pharmacol. 1997. PMID: 9300264

10

The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.

Schober DA, Van Abbema AM, Smiley DL, Bruns RF, Gehlert DR. Schober DA, et al. Among authors: gehlert dr. Peptides. 1998;19(3):537-42. doi: 10.1016/s0196-9781(97)00455-5. Peptides. 1998. PMID: 9533642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters